Showing results (451-460 of 4,360) with videos related to
Sort By:
Pageof 436
Journal of Molecular Neuroscience : MN|January 31, 2002
Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeuticsP C Wong, H Cai, D R Borchelt, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
Amyloid peptide toxicity and microtubule-stabilizing drugsMary L Michaelis, Yingxue Chen, Sarah Hill, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
Alzheimer's therapeutics: neurotrophin small molecule mimeticsStephen M Massa, Youmei Xie, Frank M LongoJournal of Molecular Neuroscience : MN|September 6, 2002
Slowing the progression of cognitive decline in Alzheimer's disease using mifepristoneJoseph K Belanoff, Jennifer Jurik, Lindsey D Schatzberg, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
Estrogen and cognitive functioning in men with mild cognitive impairmentBarbara B SherwinJournal of Molecular Neuroscience : MN|September 6, 2002
Effects of aerobic fitness training on human cortical function: a proposalArthur F Kramer, Stanley Colcombe, Kirk Erickson, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathwayHan Tun, Laura Marlow, Inga Pinnix, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomersJiaxin Yu, Lara Bakhos, Lei Chang, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
Continuing strategies for inhibiting Alzheimer's gamma-secretaseMichael S Wolfe, William P Esler, Chittaranjan DasJournal of Molecular Neuroscience : MN|September 6, 2002
Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesionKhalid Iqbal, Alejandra del C Alonso, Ezzat El-Akkad, et al.Pageof 436